FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

703880007: Efinaconazole (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3010238010 Efinaconazole en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3010777012 Efinaconazole (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Efinaconazole Is a Triazole antifungal true Inferred relationship Some
Efinaconazole This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antifungal true Inferred relationship Some
Efinaconazole Is a Triazole derivative false Inferred relationship Some
Efinaconazole Is a Azole antifungal false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Efinaconazole 100 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Efinaconazole Inferred relationship Some
Product containing efinaconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Efinaconazole Inferred relationship Some 1
Product containing only efinaconazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Efinaconazole Inferred relationship Some 1
Efinaconazole 100 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Efinaconazole Inferred relationship Some 1
Efinaconazole 100 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Efinaconazole Inferred relationship Some 1
Efinaconazole only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Efinaconazole Inferred relationship Some 1
Product containing efinaconazole in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Efinaconazole Inferred relationship Some 1

This concept is not in any reference sets

Back to Start